# A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2

> **NCT04547790** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 101 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Psyllium
- **DIETARY_SUPPLEMENT:** Wheat Dextrin

## Key facts

- **NCT ID:** NCT04547790
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-23
- **Primary completion:** 2023-11-27
- **Final completion:** 2023-11-27
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2024-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04547790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04547790, "A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04547790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*